Abstract
Depression-like behavior induced by YM643, a consensus interferon-α (IFN-α), was evaluated with the tail-suspension test in mice and compared with depression-like behavior induced by sumiferon, a natural IFN-α. To investigate the mechanism of IFN-α-induced depression-like behavior, the effects of the tricyclic antidepressant imipramine, the cyclooxygenase inhibitor indomethacin, the opioid receptor antagonist naloxone, and the selective corticotropin-releasing hormone receptor antagonist CP-154,526 on IFN-α-induced depression-like behavior were evaluated. Intravenously injected YM643 (2 × 108–2 × 109 U/kg) and sumiferon (2 × 106–2 × 107I.U./kg) dose-dependently increased immobility time. Repeated s.c. injection of either YM643 (6 × 106–6 × 108 U/kg) or sumiferon (6 × 104–6 × 106 I.U./kg) for 7 days also dose-dependently increased immobility time. After i.c.v. injection of either YM643 (2 × 106 U/mouse) or sumiferon (6 × 104I.U./mouse), significant prolongation of immobility time also was observed. Pretreatment with imipramine (30 mg/kg s.c.) significantly reduced the YM643- or sumiferon-induced increases in immobility time. CP-154,526 (0.3–3 mg/kg s.c.) dose-dependently reduced YM643- or sumiferon-induced increases in immobility time with ID50values of 0.6 mg/kg against YM643 and 1.3 mg/kg against sumiferon. However, neither indomethacin (10 mg/kg s.c.) nor naloxone (3 mg/kg s.c.) had any effect on YM643- or sumiferon-induced increases in immobility time. These results suggest that IFN-α centrally induces depression-like behavior in mice that can be alleviated with imipramine. The results also suggest that activation of corticotropin-releasing hormone receptors is involved in IFN-α-induced depression-like behavior, but the prostaglandin and opioid systems do not participate in this process.
Footnotes
-
Send reprint requests to: Mayumi Yamano Ph.D., Applied Pharmacology Research, Pharmacology Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co. Ltd., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan. E-mail: yamano{at}yamanouchi.co.jp
- Abbreviations:
- IFN-α
- interferon-α
- PG
- prostaglandin
- CNS
- central nervous system
- CRH
- corticotropin-releasing hormone
- IL-1β
- interleukin-1β
- Received July 1, 1999.
- Accepted September 8, 1999.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|